#Novo Nordisk
-
Novo Nordisk Drops 7.7% as Investor Day Fails to Revive Turnaround Case
Novo Nordisk shares fell as much as 7.7% after its investor day left markets unconvinced that the drugmaker can quickly…
-
Novo Nordisk Stock at $50: Wegovy Pill Fuels Recovery Amid Lilly Pressure
Novo Nordisk shares have rebounded from a 52-week low of $35.12 to about $50, but remain roughly 75% below their…
-
Novo Nordisk Stock Tests Turnaround After $149 Wegovy Pill Launch
Novo Nordisk shares hovered near $44 after a steep multiyear decline, as investors weigh the UK approval of an oral…